We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current OBI market cap is 11.43M. The company's latest EPS is CAD -0.0996 and P/E is -0.59.
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Total Revenue | 373k | 464k | 1.79M | 2.57M | 638k |
Operating Income | -16.53M | -14.03M | -15.87M | -17.52M | -18.76M |
Net Income | -16.85M | -13.9M | -16.27M | -50.09M | -19.37M |
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Total Assets | 4.5M | 2.91M | 2.64M | 34.14M | 16.57M |
Total Liabilities | 22.4M | 28.99M | 36.46M | 4.48M | 4.93M |
Total Equity | -17.9M | -26.07M | -33.83M | 29.66M | 11.64M |
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Operating | -10.08M | -7.55M | -6.33M | -12.54M | -16.35M |
Investing | -134k | -33k | 2.9M | -77k | -311k |
Financing | 10.17M | 6.58M | 3.83M | 41.9M | -275k |
Market Cap | 11.43M |
Price to Earnings Ratio | -0.59 |
Price to Sales Ratio | 17.79 |
Price to Cash Ratio | 0.87 |
Price to Book Ratio | 0.98 |
Dividend Yield | - |
Shares Outstanding | 194.58M |
Average Volume (1 week) | 314.41k |
Average Volume (1 Month) | 279.02k |
52 Week Change | -69.08% |
52 Week High | 19.50 |
52 Week Low | 5.75 |
Spread (Intraday) | 0.25 (4.17%) |
Company Name | Ondine Biomedical Inc. |
Address |
888 – 1100 melville street vancouver, british columbia V6E 4A6 |
Website | https://ondinebio.com |
Industry | minrls,earths-ground,treated (3295) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions